Topics
All Topics

Jun
16

The New York Times: Most Coronavirus Tests Cost About $100. Why Did One Cost $2,315?

 HCCI's research with iFHP on international comparisons of health care prices was cited in an article in The New York Times on COVID-19 test prices.  From the article:  "How can a simple coronavirus test cost $100 in one lab and 2,200 percent more in another? It comes back to a fundamental fact about the American health care system: The government does not regulate health care price...
Continue reading
Feb
13

HCCI releases 2018 Health Care Cost and Utilization Report

Per-Person Health Care Spending Grew 18% from 2014 to 2018, Driven Mostly by Prices After remaining stable for several years, utilization increased slightly in 2018 Access the report here. WASHINGTON D.C. — Average employer-sponsored insurance (ESI) spending rose to $5,892 per person in 2018, according to the Health Care Cost Institute's annual Health Care Cost and Utilization Report, which analyz...
Continue reading
Dec
27

The New York Times: In the U.S., an Angioplasty Costs $32,000. Elsewhere? Maybe $6,400.

HCCI's work with iFHP on international comparisons of health care prices was featured in a New York Times article.   In the U.S., an Angioplasty Costs $32,000. Elsewhere? Maybe $6,400. - The New York Times Enter some description here... https://www.nytimes.com/2019/12/27/upshot/expensive-health-care-world-comparison.html?smid=nytcore-ios-share
Dec
17

Vox: A CT scan costs $1,100 in the US — and $140 in Holland

HCCI's work with iFHP on international comparisons of health care price was featured in a Vox article.   America’s health care costs problem, explained in 4 charts - Vox America’s health care prices problem, in four charts. https://www.vox.com/policy-and-politics/2019/12/17/21024614/us-health-care-costs-medical-prices
Dec
17

International comparisons of health care prices from the 2017 iFHP survey

The International Federation of Health Plans (iFHP), a CEO network of the global health insurance industry based in London, in partnership with the Health Care Cost Institute (HCCI) in the United States, and iFHP member companies in eight countries, today published the latest International Comparison of Health Prices Report. The report compares the median prices paid by a sample of private he...
Continue reading
Sep
12

Insulin Use Explains Variation in Level, but not Growth, of Out-of-Pocket Spending on Insulin Products

We previously published two blogs discussing trends in out-of-pocket spending on insulin products. First, we presented data illustrating how average monthly out-of-pocket spending in 2017 varied considerably by month, particularly for individuals enrolled in consumer-directed health plans (CDHPs) that carry higher deductibles. Second, we examined the relationship between increasing point-of-sale p...
Continue reading
Sep
12

Rising Point-of-Sale Prices for Insulin Correspond with Higher Out-of-Pocket Spending on Insulin in January

Earlier this week we presented data on out-of-pocket spending on insulin during each month in 2017. In that blog, we showed that enrollees in employer-sponsored health insurance paid more out-of-pocket for insulin products at the beginning of the calendar year. We examined the relationship between increasing point-of-sale prices for insulin and higher out-of-pocket spending in January for a subset...
Continue reading
Sep
10

Out-of-Pocket Spending on Insulin is Highest at the Beginning of the Year

People who get health insurance through their jobs pay more than twice as much for insulin at the beginning of the year than they do at the end of the year, on average. New analysis of HCCI data shows that, nationally, in January 2017, average out-of-pocket spending on insulin was $105. This spending declined every month throughout the calendar year, likely as enrollees met their annual deductible...
Continue reading
Jul
29

Health Care Spending in New York Growing Faster Than Rest of U.S.

Spending per person in employer-sponsored plans reaches all-time high of $6,335 Health care spending for the average New Yorker with employer-sponsored health insurance is increasing faster in New York State than the rest of the country, according to a new analysis released today by the New York State Health Foundation (NYSHealth) and the Health Care Cost Institute (HCCI). Per-person spending grew...
Continue reading
Apr
03

The New York Times: Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin

HCCI's research on rising insulin list prices was recently cited by The New York Times in its reporting on Express Scripts' new plan to offer a $25 cap for month insulin. From the article: "Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced on Wednesday. The move is aimed at addressing rising an...
Continue reading
Feb
19

2017 Annual Health Care Cost and Utilization Report Webinar

Watch the Webinar HCCI recently held a webinar to discuss the 2017 Annual Health Care Cost and Utilization Report.    Download PDF File Here
Feb
11

2017 Health Care Cost and Utilization Report

The 2017 Health Care Cost and Utilization Report shows that spending per privately insured person grew by 4.2 percent, the second year in a row of spending growth over four percent. Price increases were the primary driver. The report covers the period 2013 through 2017 and includes claims data from four national insurance companies: Aetna, Humana, Kaiser Permanente, and UnitedH...
Continue reading
Jan
28

HCCI Insulin Report Receives Extensive Media Coverage

 HCCI's recent report on trends in rising insulin prices received additional media coverage in the last week in outlets including NBC, CBS, CNN, The New York Times, The Hill, U.S. News & World Report, and USA Today.  From CNN: "Congress and the Trump administration continue to push for a drug pricing plan and were given more ammunition Tuesday in the form of a report documenting...
Continue reading
Jan
22

Reuters: U.S. Insulin Costs Per Patient Nearly Doubled From 2012 to 2016: Study

​HCCI's latest research on rising insulin prices was recently featured in Reuters. HCCI's report detailed both use and price trends of insulin used by those with type 1 diabetes from 2012 to 2016. Per Reuters article: "A person with type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that at $2,864 per patient in 2012, according to a...
Continue reading
Jan
21

Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices

We used health care claims data to investigate trends in total health care spending on individuals with type 1 diabetes between 2012 and 2016. We found a rapid increase in total health care spending, driven primarily by gross spending on insulin that doubled over the period. During that time insulin use rose only modestly. While the composition of insulins used shifted, the price of all types of i...
Continue reading
Sep
19

Health Affairs: Health Care Spending Under Employer-Sponsored Insurance: A 10-Year Retrospective

ABSTRACT Using a national sample of health care claims data from the Health Care Cost Institute, we found that total spending per capita (not including premiums) on health services for enrollees in employer-sponsored insurance plans increased by 44 percent from 2007 through 2016 (average annual growth of 4.1 percent). Spending increased across all major categories of health services, although the ...
Continue reading
Jun
19

2016 Health Care Cost and Utilization Report

The 2016 Health Care Cost and Utilization Report shows that spending per privately insured person grew by 4.6 percent, faster than in previous years. Price increases were the primary driver. The report covers the period 2012 through 2016 and includes claims data from four national insurance companies: Aetna, Humana, Kaiser Permanente, and UnitedHealthcare.​  The data in the report can al...
Continue reading
Apr
24

Interactive Tool: Disease Modifying Therapies Drove 82% of Total Increase in Health Care Spending for People with Multiple Sclerosis

In a recent issue brief, HCCI found that the already high cost of care for people with multiple sclerosis (MS) rose dramatically over the past several years. The primary driver was the increasing cost of a small group of prescription drugs called Disease Modifying Therapies (DMTs). To illustrate the role prescription drug prices play in driving overall health care spending for people with MS, we d...
Continue reading
Apr
12

Health Exec: Drug competition didn’t stop sharp increase in MS spending

By: John Gregory  Between 2009 and 2015, spending on patients with multiple sclerosis (MS) greatly increased, with disease modifying therapies (DMTs) accounting for 82 percent of that increase as prices jumped every year and use slightly declined. The report from the Health Care Cost Institute (HCCI) examined claims for people with MS from 2009 to 2015 covered by individual market, employer-s...
Continue reading
Apr
12

The Rising Cost of Specialty Drugs Drove Spending Increases for People with Multiple Sclerosis

This issue brief investigates how the cost of prescription drugs affects the total cost of care for people with multiple sclerosis (MS). It decomposes total health care spending by category, specifically separating out spending on specialty drugs used to treat MS, called Disease Modifying Therapies (DMTs). The issue brief subsequently examines whether changes in spending on DMTs are due to changes...
Continue reading
Mar
14

Under Pressure - Adults with Hypertension are Spending Increasingly More on Health Care

This issue brief compares trends in health care spending from 2012 to 2016 for adults with employer-sponsored insurance who were diagnosed with hypertension to those not diagnosed with hypertension. It also considers how changes in prescription drug spending compare to changes in prescription drug use for adults with a hypertension diagnosis.   Excel Data Tables Machine-Readable Data   D...
Continue reading
Feb
01

Top Spenders Among the Commercially Insured Increased Spending Concentration and Consistent Turnover from 2013 to 2015

 This issue brief explores the distribution of health care spending among commercially insured individuals, with a focus on the top 5 percent of spenders and turnover within that group from year to year. It considers the share of spending incurred by this group of top spenders, how those dollars are distributed among the health care service categories, turnover within the group of top spender...
Continue reading
Jan
24

Wall Street Journal: Health-Care Costs Rose for Americans With Employer-Sponsored Insurance

By: Jeanne Whalen Spending on health care accelerated in 2016 for Americans who get insurance through work, even as use of most health-care services declined or remained flat. The reason, according to a new report: price increases. Rising prices for prescription drugs, surgery, emergency-room visits and other services drove a 4.6% increase in total spending per person, versus 4.1% in 2015 and less...
Continue reading
Jan
05

Doctors Lounge: Socioeconomic Factors Associated With Opioid Prescriptions

​Among disabled Medicare beneficiaries, county-level socioeconomic factors are associated with opioid prescriptions, with more prescriptions seen with lower socioeconomic indicators, according to a study published in the January issue of Medical Care. Chao Zhou, Ph.D., from the Health Care Cost Institute in Washington, D.C., and colleagues examined opioid prescriptions of disabled Medicare benefic...
Continue reading
Nov
29

Price of insulin prescription doubled between 2012 and 2016

In honor of National Diabetes Month, our inaugural blog post focuses on a topic of particular interest to people with diabetes: the price of insulin. Insulin is the hormone responsible for the body's ability to use sugar and prevent dangerously high and potentially deadly levels of blood sugar. Diabetics are unable to make enough insulin to support their bodies' needs, and thus many are dependent ...
Continue reading